Big Pharma operates outside of the US... IMU should be seeking to license IP in other territories. Obviously the US is the largest market, they could maintain ownership of this opportunity (for 4+ years if required) without continuing to dilute retail to oblivion.
Management appear to be asleep at the wheel. Why not investigate why the best PD1-VAXX response rate was at 1/10 the dose they are currently using?
Hopper doesn't seem to care as he continues to pick up free options at every 'bargain basement' price.
IMU Price at posting:
4.1¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)